ORCID
- Carroll, Camille: 0000-0001-7472-953X
DOI
10.1007/s40120-023-00554-w
Publication Date
2023-10-10
Embargo Period
2024-03-14
Organisational Unit
Peninsula Medical School
Recommended Citation
Aldred, J., Freire-Alvarez, E., Amelin, A., Antonini, A., Bergmans, B., Bergquist, F., Bouchard, M., Budur, K., Carroll, C., Chaudhuri, K., Criswell, S., Danielsen, E., Gandor, F., Jia, J., Kimber, T., Mochizuki, H., Robieson, W., Spiegel, A., Standaert, D., Talapala, S., Facheris, M., & Fung, V. (2023) 'Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study', Available at: https://doi.org/10.1007/s40120-023-00554-w
